Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have advanced liver cancer (a liver tumour that cannot be treated with local treatments due to how far it has spread, or a liver tumour that came back after local treatment was done)
- People whose cancer has not responded to at least two previous treatments, who are no longer eligible for any standard treatment, or who were unable to tolerate at least two previous treatments
- People whose cancer can be measured or assessed by doctors to track changes
- People who are 22 years of age or older and are able to understand and sign a consent form
- Female patients who could become pregnant, their partners, and male patients must agree to use adequate contraception throughout the study treatment period
- People who are expected to live for at least 3 months
Who may not be able to join:
- People who have another active cancer, unless the trial investigator considers it unlikely to affect the study's safety or results
- People who are currently taking another experimental or investigational drug
- People who have active inflammation, ulcers, or other conditions affecting the inside of the mouth that could interfere with use of the study device
- People who are currently taking calcium channel blockers or similar medications (such as amlodipine, nifedipine, ethosuximide, or vitamin C) unless those medications are stopped before the study treatment begins, and participants must agree not to take these medications for the entire duration of the study treatment
- People who are currently breastfeeding (breastfeeding would need to be stopped before participation could be considered)
- People who are unwilling to follow the study schedule, or who are physically or cognitively unable to use the study device as required (three 60-minute sessions per day — morning, midday, and evening)
- People who have a known severe allergy (such as anaphylaxis) to nickel
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anthony F Shields, M.D., Wayne State University
Phone: 313-576-8735
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.